Showing results (91-100 of 194) with videos related to
Sort By:
Pageof 20
The Oncologist|May 13, 2017
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of EncephalitisJames Larkin, Bartosz Chmielowski, Christopher D Lao, et al.Plos One|December 24, 2011
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathwayMohammad Atefi, Erika von Euw, Narsis Attar, et al.Cell Cycle (Georgetown, Tex.)|April 21, 2017
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) modelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humansRong Rong Huang, Jason Jalil, James S Economou, et al.Cancers|August 28, 2020
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue SarcomaDanielle S Graham, Ritchell van Dams, Nicholas J Jackson, et al.Journal for Immunotherapy of Cancer|March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanomaGeoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomasPuja Kachroo, Peter S Pak, Harpavan S Sandha, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.Journal of Cellular Biochemistry|January 21, 2017
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse ModelKei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.European Journal of Cancer (Oxford, England : 1990)|May 19, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progressionIgor Puzanov, Ravi K Amaravadi, Grant A McArthur, et al.Pageof 20